FIBRALIGN CORPORATION

Fibralign Corporation utilizes Nanoweave® a proprietary scaffolding technology to develop advanced biomedical devices. Fibralign has launched its first product, the BioBridge® Collagen Matrix, and is now engaging in clinical studies to evaluate its use for treating and preventing secondary lymphedema, as well as advancing R&D development for new applications for treating ischemia and novel delivery devices for use with stem cells and gene therapy.

#People #Financial #Website #More

FIBRALIGN CORPORATION

Social Links:

Twitter

Industry:

Biotechnology Clinical Trials Medical Medical Device Therapeutics

Founded:

2007-01-01

Address:

Sunnyvale, California, United States

Country:

United States

Website Url:

http://www.fibralignbio.com

Total Employee:

Status:

Active

Contact:

8313358348

Email Addresses:

[email protected]

Total Funding:

179.96 K USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Sitelinks Search Box

Current Advisors List

william-bill-hyun_image

William (Bill) Hyun Scientific Advisor and Investor @ Fibralign Corporation
Advisor
2008-07-01

Current Employees Featured

michael-paukshto_image

Michael Paukshto
Michael Paukshto Founder and CTO @ Fibralign Corporation
Founder and CTO
2008-03-01

Founder

michael-paukshto_image

Michael Paukshto

Investors List

angel-md_image

Official Site Inspections

http://www.fibralignbio.com Semrush global rank: 5.97 M Semrush visits lastest month: 1.38 K

Host Informations
Whois Informations

Loading ...